다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Gastroentérologie clinique et biologique, v.34 suppl.1, 2010년, pp.S44 - S51
Seksik, P.
AI-Helper
Gut microbiota contains about 10(14) bacterial cells classified within 4 bacterial phyla, namely Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria. Much of the information has been generated through the application of nucleic acid-based methodologies (16S rRNA) which provide a cornerston...
Gastroenterology Elson 109 1344 1995 10.1016/0016-5085(95)90599-5 Experimental models of inflammatory bowel disease
Gastroenterology Swidsinski 122 44 2002 10.1053/gast.2002.30294 Mucosal flora in inflammatory bowel disease
Gut Harper 26 279 1985 10.1136/gut.26.3.279 Role of the faecal stream in the maintenance of Crohn's colitis
10.1016/0140-6736(91)90663-A Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 199;338:771-4.
Gut Llopis 54 955 2005 10.1136/gut.2004.056101 Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid
Gastroenterology Kim 128 891 2005 10.1053/j.gastro.2005.02.009 Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria
Cell Garrett 131 33 2007 10.1016/j.cell.2007.08.017 Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system
Nature Hugot 411 599 2001 10.1038/35079107 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Science Kobayashi 307 731 2005 10.1126/science.1104911 Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract
Am J Gastroenterol Economou 99 2393 2004 10.1111/j.1572-0241.2004.40304.x Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis
Science Duerr 314 1461 2006 10.1126/science.1135245 A genome-wide association study identifies IL23R as an inflammatory bowel disease gene
Nat Genet Rioux 39 596 2007 10.1038/ng2032 Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis
Gut Wehkamp 53 1658 2004 10.1136/gut.2003.032805 NOD2 (CARD15) mutations in Crohn‘s disease are associated with diminished mucosal {alpha}-defensin expression
Inflamm Bowel Dis Wehkamp 9 215 2003 10.1097/00054725-200307000-00001 Inducible and constitutive beta-defensins are differentially expressed in Crohn‘s disease and ulcerative colitis
Gut Simms 57 903 2008 10.1136/gut.2007.142588 Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn‘s disease
Gut Macpherson 38 365 1996 10.1136/gut.38.3.365 Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
Infect Immun Cohavy 68 1542 2000 10.1128/IAI.68.3.1542-1548.2000 Colonic bacteria express an ulcerative colitis pANCA-related protein epitope
Gastroenterology Darfeuille-Michaud 115 1405 1998 10.1016/S0016-5085(98)70019-8 Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn‘s disease
Gastroenterology Darfeuille-Michaud 127 412 2004 10.1053/j.gastro.2004.04.061 High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease
Inflamm Bowel Dis Carvalho 14 1051 2008 10.1002/ibd.20423 Crohn's disease-associated Escherichia coli LF82 aggravates colitis in injured mouse colon via signaling by flagellin
J Clin Invest Barnich 117 1566 2007 10.1172/JCI30504 CEACAM6 acts as a receptor for adherentinvasive E. coli, supporting ileal mucosa colonization in Crohn disease
Clin Microbiol Infect Schwartz 6 303 2000 10.1046/j.1469-0691.2000.00093.x Use of short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients
Am J Gastroenterol Hulten 96 1529 2001 10.1111/j.1572-0241.2001.03751.x Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization
Lancet Naser 364 1039 2004 10.1016/S0140-6736(04)17058-X Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease
Gastroenterology Selby 132 2313 2007 10.1053/j.gastro.2007.03.031 Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
Appl Environ Microbiol Suau 65 4799 1999 10.1128/AEM.65.11.4799-4807.1999 Direct analysis of genes encoding 16S rRN A from complex communities reveals many novel molecular species within the human gut
J Med Microbiol Giaffer 35 238 1991 10.1099/00222615-35-4-238 The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique
Gut Seksik 52 237 2003 10.1136/gut.52.2.237 Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
J Clin Microbiol Scanlan 44 3980 2006 10.1128/JCM.00312-06 Cultureindependent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease
Inflamm Bowel Dis Sokol 12 106 2006 10.1097/01.MIB.0000200323.38139.c6 Specificities of the Fecal Microbiota in Inflammatory Bowel Disease
FEMS Microbiol Ecol Mangin 50 25 2004 10.1016/j.femsec.2004.05.005 Molecular inventory of faecal microflora in patients with Crohn's disease
Gut Manichanh 55 205 2006 10.1136/gut.2005.073817 Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
J Clin Microbiol Sokol 44 3172 2006 10.1128/JCM.02600-05 Temperature Gradient Gel Electrophoresis of Fecal 16S rRNA Reveals Active Escherichia coli in the Microbiota of Patients with Ulcerative Colitis
J Clin Microbiol Swidsinski 43 3380 2005 10.1128/JCM.43.7.3380-3389.2005 Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
J Clin Microbiol Gophna 44 4136 2006 10.1128/JCM.01004-06 Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis
Proc Natl Acad Sci U S A Frank 104 13780 2007 10.1073/pnas.0706625104 Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Inflamm Bowel Dis Martinez-Medina 12 1136 2006 10.1097/01.mib.0000235828.09305.0c Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis
Gut Kotlowski 56 669 2007 10.1136/gut.2006.099796 High prevalence of Escherichia coli belonging to the B2+ D phylogenetic group in inflammatory bowel disease
Gut Sokol 56 152 2007 10.1136/gut.2006.109686 Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis
J Clin Microbiol Zhang 45 496 2007 10.1128/JCM.01720-06 Structural shifts of mucosa-associated lactobacilli and Clostridium leptum subgroup in patients with ulcerative colitis
Inflamm Bowel Dis Mylonaki 11 481 2005 10.1097/01.MIB.0000159663.62651.4f Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease
Proc Natl Acad Sci U S A Sokol 105 16731 2008 10.1073/pnas.0804812105 Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
J Clin Microbiol Seksik 43 4654 2005 10.1128/JCM.43.9.4654-4658.2005 Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA
Gut Ott 53 685 2004 10.1136/gut.2003.025403 Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease
Gut Giaffer 33 646 1992 10.1136/gut.33.5.646 Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease
Curr Issues Intest Microbiol Bullock 5 59 2004 Comparative composition of bacteria in the human intestinal microflora during remission and active ulcerative colitis
Gut Pitcher 46 64 2000 10.1136/gut.46.1.64 The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis
Gut Conte 55 1760 2006 10.1136/gut.2005.078824 Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.